Arrogene Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

Arrogene General Information

Description

Developer of targeted cancer treatment technologies designed to inhibit tumor progression. The company's nanomedicine platform to delivers nano agents like peptide, protein, and oligonucleotide therapeutics across the blood-brain barrier to cancer cells to prevent tumor growth and immunochemistry for diagnostics and prognostics, enabling healthcare professionals to reduce the spreading of cancer cells in patients.

Contact Information

Formerly Known As
SRKP 16, Srkp 16 Inc
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 8560 West Sunset Boulevard
  • Suite 424
  • Los Angeles, CA 90069
  • United States
+1 (424)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 8560 West Sunset Boulevard
  • Suite 424
  • Los Angeles, CA 90069
  • United States
+1 (424)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Arrogene Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Out of Business 07-Mar-2023 Completed Out of Business
8. Later Stage VC 30-Oct-2019 Completed Generating Revenue
7. Later Stage VC 08-May-2018 Completed Generating Revenue
6. Grant 21-Sep-2016 Completed Generating Revenue
5. Angel (individual) 18-Mar-2016 Completed Generating Revenue
4. Angel (individual) 02-Jan-2015 Completed Generating Revenue
3. Seed Round 06-Mar-2013 Completed Generating Revenue
2. Angel (individual) 01-Oct-2010 $727K $734K Completed Generating Revenue
1. Angel (individual) 28-Sep-2007 $7.5K $7.5K Completed Generating Revenue
To view Arrogene’s complete valuation and funding history, request access »

Arrogene Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of targeted cancer treatment technologies designed to inhibit tumor progression. The company's nanomedicine pl
Drug Discovery
Los Angeles, CA

Pasadena, CA
 

Plymouth Meeting, PA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Arrogene Competitors (44)

One of Arrogene’s 44 competitors is Meditope Biosciences, a Formerly VC-backed company based in Pasadena, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Meditope Biosciences Formerly VC-backed Pasadena, CA
Inovio Pharmaceuticals Corporation Plymouth Meeting, PA
Xenetic Biosciences Corporation Framingham, MA
Kite Pharma Formerly VC-backed Santa Monica, CA
Adaptimmune Therapeutics Formerly VC-backed Abingdon, United Kingdom
You’re viewing 5 of 44 competitors. Get the full list »

Arrogene Patents

Arrogene Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
ES-2717836-T3 Multifunctional drug delivery system based on polymic acid Inactive 05-Dec-2003
US-20070259008-A1 Polymalic acid-based multi-functional drug delivery system Active 05-Dec-2003
US-7935677-B2 Polymalic acid-based multi-functional drug delivery system Inactive 05-Dec-2003
EP-1689443-A2 Polymalic acid-based multifunctional drug delivery system Active 05-Dec-2003
EP-1689443-B1 Polymalic acid-based multifunctional drug delivery system Inactive 05-Dec-2003 A61K47/6883
To view Arrogene’s complete patent history, request access »

Arrogene FAQs

  • When was Arrogene founded?

    Arrogene was founded in 2006.

  • Where is Arrogene headquartered?

    Arrogene is headquartered in Los Angeles, CA.

  • What industry is Arrogene in?

    Arrogene’s primary industry is Drug Discovery.

  • Is Arrogene a private or public company?

    Arrogene is a Private company.

  • What is Arrogene’s current revenue?

    The current revenue for Arrogene is .

  • How much funding has Arrogene raised over time?

    Arrogene has raised $7.7M.

  • Who are Arrogene’s competitors?

    Meditope Biosciences, Inovio Pharmaceuticals, Xenetic Biosciences, Kite Pharma, and Adaptimmune Therapeutics are some of the 44 competitors of Arrogene.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process